Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

NCT06126601 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT06126601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Recruiting
Start date
July 18, 2023
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperamylasemia, pancreatectomy, pancreatitis, acute